레보설피리드 제조용 중간체 및 그 제조방법
    2.
    发明授权
    레보설피리드 제조용 중간체 및 그 제조방법 有权
    请务必使用符合条件的文件

    公开(公告)号:KR100450485B1

    公开(公告)日:2004-10-01

    申请号:KR1020030069901

    申请日:2003-10-08

    Abstract: PURPOSE: An intermediate for preparing levosulpiride and a preparation method thereof are provided, thereby preparing levosulpiride in higher yield and purity. CONSTITUTION: An intermediate represented by the formula (V) for preparing levosulpiride of the formula (I) is provided, wherein R1 and R2 are independently hydrogen, C1-C4 lower alkyl or phenyl; R3 is phenyl derivative of the formula (VIII) or naphthyl derivative of the formula (IX); and X is hydrogen or halogen, provided that the formula (V) may be racemic body, (S) body and (R) body because it contains chiral carbon(*). A method for preparing an intermediate of the formula (V) for preparing levosulpiride comprises activating a compound of the formula (IV) in the presence of base using acid anhydride method, acid chloride method or azide method, and reacting the activated compound of the formula (IV) with 2-methoxy-5-sulfamoyl benzoic acid, wherein R1 and R2 are independently hydrogen, C1-C4 lower alkyl or phenyl; R3 is phenyl derivative of the formula (VIII) or naphthyl derivative of formula (IX); and X is hydrogen or halogen.

    Abstract translation: 目的:提供一种制备左磺舒钠的中间体及其制备方法,由此以较高的收率和纯度制备左磺舒钠。 构成:提供了用于制备式(I)左磺舒醇酯的由式(V)表示的中间体,其中R 1和R 2独立地为氢,C 1 -C 4低碳烷基或苯基; R3是式(VIII)的苯基衍生物或式(IX)的萘基衍生物; X是氢或卤素,条件是式(V)可以是外消旋体,(S)体和(R)体,因为它含有手性碳(*)。 用于制备用于制备左磺柳碱的式(V)中间体的方法包括使用酸酐法,酰氯法或叠氮化物法在碱的存在下活化式(IV)的化合物,并且使活化的式 (IV)与2-甲氧基-5-氨磺酰基苯甲酸反应,其中R1和R2独立地为氢,C1-C4低级烷基或苯基; R3是式(VIII)的苯基衍生物或式(IX)的萘基衍生物; 并且X是氢或卤素。

    레보설피리드 제조용 중간체 및 그 제조방법
    3.
    发明公开
    레보설피리드 제조용 중간체 및 그 제조방법 有权
    制备精神病毒素的中间体及其制备方法

    公开(公告)号:KR1020030082526A

    公开(公告)日:2003-10-22

    申请号:KR1020030069903

    申请日:2003-10-08

    Abstract: PURPOSE: Provided are an intermediate for preparing levosulpiride and a preparation method thereof, thereby preparing levosulpiride in higher yield and purity. CONSTITUTION: An intermediate represented by the formula (IV) for preparing levosulpiride of the formula (I) is provided, wherein R1 and R2 are independently hydrogen, C1-C4 lower alkyl or phenyl; R3 is phenyl derivative of the formula (VIII) or naphthyl derivative of the formula (IX); and X is hydrogen or halogen, provided that the formula (IV) may be racemic body, (S) body and (R) body because it contains chiral carbon(*). A method for preparing an intermediate of the formula (IV) for preparing levosulpiride comprises reducing a compound of the formula (III) with a reducing agent, wherein R1 and R2 are independently hydrogen, C1-C4 lower alkyl or phenyl; R3 is phenyl derivative of the formula (VIII) or naphthyl derivative of the formula (IX); and X is hydrogen or halogen.

    Abstract translation: 目的:提供制备左布舒地平的中间体及其制备方法,从而以更高的产率和纯度制备左布舒地尔。 构成:提供由式(IV)表示的用于制备式(I)的左布列脲的中间体,其中R 1和R 2独立地为氢,C 1 -C 4低级烷基或苯基; R3是式(VIII)的苯基衍生物或式(IX)的萘基衍生物; 并且X是氢或卤素,条件是式(IV)可以是外消旋体,(S)体和(R)体,因为它含有手性碳(*)。 制备式(IV)的中间体的方法,用于制备左旋肉豆蔻酸盐包括用还原剂还原式(III)化合物,其中R 1和R 2独立地是氢,C 1 -C 4低级烷基或苯基; R3是式(VIII)的苯基衍生物或式(IX)的萘基衍生物; X为氢或卤素。

    광학 활성을 갖는 옥시라세탐의 제조 방법
    4.
    发明授权
    광학 활성을 갖는 옥시라세탐의 제조 방법 失效
    制备S或R-OXIRACETAM的方法

    公开(公告)号:KR100679633B1

    公开(公告)日:2007-02-07

    申请号:KR1020040058550

    申请日:2004-07-27

    Abstract: 본 발명은 뇌기능 개선작용 및 치매 치료 효과를 나타내는 1-카바모일메틸-4-하이드록시-2-피롤리디논(옥시라세탐)의 광학 (S)-이성체 또는 (R)-이성체를 용이하게 제조하는 방법에 관한 것으로, 본 발명에 따라 1-(S 또는 R)-페닐에틸-4-(S 또는 R)-히드록시-2-피롤리디논을 유기용매 존재 하에 아세틸화시키고, 생성된 1-(S 또는 R)-페닐에틸-4-(S 또는 R)-아세톡시-2-피롤리디논을 유기용매 존재 하에 탈벤질화 시킨 후, 생성된 4-(S 또는 R)-알콕시-2-피롤리디논을 유기용매 및 염기 존재 하에 할로겐으로 치환된 아세테이트와 반응시킨 다음, 생성된 1-에톡시카보닐메틸-4-(S 또는 R)-2-피롤리디논을 암모니아와 반응시키는 단계를 포함하는 1-카바모일-4-(S 또는 R)-히드록시-2-피롤리디논의 제조방법은 저가의 원료물질들을 사용하여 산업적 적용이 용이한 공정으로 (S)-옥시라세탐 또는 (R)-옥시라세탐을 고수율 및 고순도로 제조할 수 있으므로 뇌기능 개선 및 치매 치료제 개발에 유용하게 활용될 수 있다.

    레보설피리드의 제조방법 및 이에 사용되는 중간체
    5.
    发明授权
    레보설피리드의 제조방법 및 이에 사용되는 중간체 有权
    레보설피리드의제조방법이이용되되중

    公开(公告)号:KR100432587B1

    公开(公告)日:2004-05-24

    申请号:KR1020010031027

    申请日:2001-06-02

    Abstract: PURPOSE: Provided are a method for preparing Levosulpiride which increases the pressure of a sphincteral muscle, promotes the vermiculation of the gullet and facilitates digestion, in high yield and purity and intermediates used therein. CONSTITUTION: The method for preparing Levosulpiride of the formula(I) is characterized by treating a compound of the formula(V) with trifluoroacetate. In the formulae, R1 and R2 are independently hydrogen atom or 1-4 of lower alkyl or phenyl; R3 is a phenyl derivative of the formula(VIII) or naphthyl derivative of the formula(IX).

    Abstract translation: 目的:提供一种制备左旋舒必利的方法,所述左旋舒必利增加肠内肌肉的压力,促进食道的蠕动并促进消化,其中以高收率和纯度以及其中使用的中间体。 构成:制备式(I)左磺舒醇酯的方法的特征在于用三氟乙酸盐处理式(V)化合物。 在通式中,R1和R2独立地为氢原子或1-4个低级烷基或苯基; R3是式(VIII)的苯基衍生物或式(IX)的萘基衍生物。

    광학 활성을 갖는 옥시라세탐의 제조 방법
    6.
    发明公开
    광학 활성을 갖는 옥시라세탐의 제조 방법 失效
    制备(S)或(R) - 紫杉醇的方法

    公开(公告)号:KR1020060010000A

    公开(公告)日:2006-02-02

    申请号:KR1020040058550

    申请日:2004-07-27

    Abstract: 본 발명은 뇌기능 개선작용 및 치매 치료 효과를 나타내는 1-카바모일메틸-4-하이드록시-2-피롤리디논(옥시라세탐)의 광학 (S)-이성체 또는 (R)-이성체를 용이하게 제조하는 방법에 관한 것으로, 본 발명에 따라 1-(S 또는 R)-페닐에틸-4-(S 또는 R)-히드록시-2-피롤리디논을 유기용매 존재 하에 아세틸화시키고, 생성된 1-(S 또는 R)-페닐에틸-4-(S 또는 R)-아세톡시-2-피롤리디논을 유기용매 존재 하에 탈벤질화 시킨 후, 생성된 4-(S 또는 R)-알콕시-2-피롤리디논을 유기용매 및 염기 존재 하에 할로겐으로 치환된 아세테이트와 반응시킨 다음, 생성된 1-에톡시카보닐메틸-4-(S 또는 R)-2-피롤리디논을 암모니아와 반응시키는 단계를 포함하는 1-카바모일-4-(S 또는 R)-히드록시-2-피롤리디논의 제조방법은 저가의 원료물질들을 사용하여 산업적 적용이 용이한 공정으로 (S)-옥시라세탐 또는 (R)-옥시라세탐을 고수율 및 고순도로 제조할 수 있으므로 뇌기능 개선 및 치매 치료제 개발에 유용하게 활용될 수 있다.

    레보설피리드 제조용 중간체 및 그 제조방법
    7.
    发明公开
    레보설피리드 제조용 중간체 및 그 제조방법 有权
    制备精神病毒素的中间体及其制备方法

    公开(公告)号:KR1020030082525A

    公开(公告)日:2003-10-22

    申请号:KR1020030069901

    申请日:2003-10-08

    Abstract: PURPOSE: An intermediate for preparing levosulpiride and a preparation method thereof are provided, thereby preparing levosulpiride in higher yield and purity. CONSTITUTION: An intermediate represented by the formula (V) for preparing levosulpiride of the formula (I) is provided, wherein R1 and R2 are independently hydrogen, C1-C4 lower alkyl or phenyl; R3 is phenyl derivative of the formula (VIII) or naphthyl derivative of the formula (IX); and X is hydrogen or halogen, provided that the formula (V) may be racemic body, (S) body and (R) body because it contains chiral carbon(*). A method for preparing an intermediate of the formula (V) for preparing levosulpiride comprises activating a compound of the formula (IV) in the presence of base using acid anhydride method, acid chloride method or azide method, and reacting the activated compound of the formula (IV) with 2-methoxy-5-sulfamoyl benzoic acid, wherein R1 and R2 are independently hydrogen, C1-C4 lower alkyl or phenyl; R3 is phenyl derivative of the formula (VIII) or naphthyl derivative of formula (IX); and X is hydrogen or halogen.

    Abstract translation: 目的:提供一种制备左美沙比妥的中间体及其制备方法,从而以更高的产率和纯度制备左美沙非尼。 构成:提供由式(I)表示的式(Ⅴ)表示的中间体,其中R 1和R 2独立地为氢,C 1 -C 4低级烷基或苯基; R3是式(VIII)的苯基衍生物或式(IX)的萘基衍生物; 并且X是氢或卤素,条件是式(V)可以是外消旋体,(S)体和(R)体,因为它含有手性碳(*)。 制备式(Ⅴ)中间体的制备方法,包括使用酸酐法,酰氯法或叠氮化物法在碱的存在下活化式(Ⅳ)的化合物,并使式 (IV)与2-甲氧基-5-氨磺酰基苯甲酸,其中R 1和R 2独立地是氢,C 1 -C 4低级烷基或苯基; R3是式(VIII)的苯基衍生物或式(IX)的萘基衍生物; X为氢或卤素。

    레보설피리드의 제조방법 및 이에 사용되는 중간체
    8.
    发明公开
    레보설피리드의 제조방법 및 이에 사용되는 중간체 有权
    制备利尿剂及其使用的中间体的方法

    公开(公告)号:KR1020020092123A

    公开(公告)日:2002-12-11

    申请号:KR1020010031027

    申请日:2001-06-02

    Abstract: PURPOSE: Provided are a method for preparing Levosulpiride which increases the pressure of a sphincteral muscle, promotes the vermiculation of the gullet and facilitates digestion, in high yield and purity and intermediates used therein. CONSTITUTION: The method for preparing Levosulpiride of the formula(I) is characterized by treating a compound of the formula(V) with trifluoroacetate. In the formulae, R1 and R2 are independently hydrogen atom or 1-4 of lower alkyl or phenyl; R3 is a phenyl derivative of the formula(VIII) or naphthyl derivative of the formula(IX).

    Abstract translation: 目的:提供一种制备左旋舒巴替罗的方法,其增加括约肌的压力,促进食道的呕吐并促进以高产率和纯度消化,以及其中使用的中间体。 构成:式(I)的左旋苏布里德的制备方法的特征在于用三氟乙酸盐处理式(V)的化合物。 在该式中,R 1和R 2独立地为氢原子或1-4个低级烷基或苯基; R3是式(VIII)的苯基衍生物或式(IX)的萘基衍生物。

Patent Agency Ranking